Medical Condition News

RSS

New online, sound matching tool offers tinnitus sufferers potential treatment options

A tea kettle, buzzing cicada or screeching noise? Tinnitus suffers are being invited to use a new online, sound matching tool to help better understand their type of tinnitus and the potential treatments that might be able to help them.

24 Sep 2018

Researchers analyze response to combination immunotherapy for patients with rare skin cancer

Harnessing the immune system to treat cancer shows great promise in some patients, but for many, the response does not last long-term.

24 Sep 2018

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

24 Sep 2018

Number of people with respiratory diseases likely to increase if UK air pollution remains unchecked

The number of people suffering from respiratory indications and the severity of those already suffering from the various diseases is expected to increase if air pollution in the UK goes unchecked, says GlobalData, a leading data and analytics company.

24 Sep 2018

Successful recovery from addiction means more than achieving abstinence

Successful recovery from drug and alcohol addiction through attending a residential treatment program means more to the person than just staying clean and sober, an Australian-first study has found.

24 Sep 2018

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

Seattle Genetics, Inc. today announced that its collaborator, Takeda Pharmaceutical Company Limited, has received approval from the Japanese Ministry of Health, Labour and Welfare for ADCETRIS (brentuximab vedotin) in combination with doxorubicin, vinblastine and dacarbazine as a frontline treatment option for CD30-positive Hodgkin lymphoma patients in Japan.

24 Sep 2018

Biogen and Eisai announce results of LTE Phase 1b study of aducanumab for treating MCI

Biogen and Eisai Co., Ltd. announced results from a recent analysis of the ongoing long-term extension Phase 1b study of aducanumab, an investigational treatment for mild cognitive impairment due to Alzheimer's disease and mild AD dementia.

24 Sep 2018

Place where older adults live before hospitalization may affect risk of readmission

Forty per cent of older adults who leave hospital are discharged to home care or a long-term care facility, which, combined with where they lived before hospitalization, affects their risk of readmission, found a study published in CMAJ.

24 Sep 2018

Researchers compare weight loss results of online and in-person diabetes prevention program

Researchers examined participation and weight loss results in an online diabetes prevention program; an in-person diabetes prevention program; and the Veterans Administration's face-to-face standard-of-care weight management program, called MOVE!

24 Sep 2018

Cytox, AIBL announce expanded agreement to assess genetic risk for Alzheimer’s

Cytox, a precision medicine company which today is commercializing polygenic risk scoring approaches for assessing genetic risk for developing Alzheimer's disease and other neurological diseases, has announced it has expanded its research collaboration with the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing to test new algorithms for identifying the pre-symptomatic and mild cognitively impaired people most at risk to progress to AD.

24 Sep 2018

CSU chemists may help in making extracorporeal life support devices more effective

Smoke inhalation, pneumonia, and combat-related trauma are just a few causes of acute respiratory distress syndrome - a condition where the lungs fill with fluid, and is too often fatal.

24 Sep 2018

New nanoplatform technology may reverse drug-resistance in renal cell carcinoma

A research team led by Arun Iyer, Ph.D., assistant professor of pharmaceutical sciences in the Eugene Applebaum College of Pharmacy and Health Sciences at Wayne State University, has developed a nanoplatform technology that works in combination with existing chemotherapeutic drugs that may reverse drug-resistance in renal cell carcinoma.

24 Sep 2018

Researchers highlight potential therapy for treating rare, deadly blood-clotting disorder

In proof-of-concept experiments, University of Alabama at Birmingham researchers have highlighted a potential therapy for a rare but potentially deadly blood-clotting disorder, TTP.

24 Sep 2018

CHMP recommends approval of Gilenya for treatment of multiple sclerosis in children, adolescents

Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Gilenya (fingolimod) for the treatment of children and adolescents 10 to 17 years of age with relapsing remitting forms of multiple sclerosis.

24 Sep 2018

Study: Transcatheter mitral valve repair reduces mortality for patients with mitral regurgitation

A multicenter clinical trial has found that a minimally invasive procedure called transcatheter mitral valve repair significantly reduced hospitalizations and mortality for heart failure patients with moderate-to-severe or severe functional mitral regurgitation.

24 Sep 2018

China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma

Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth N.J., U.S.A., known as MSD outside of the United States and Canada, announced that the China National Medical Products Administration approved the kinase inhibitor LENVIMA (lenvatinib) as a single agent for the treatment of patients with unresectable hepatocellular carcinoma who have not received prior systemic therapy.

24 Sep 2018

Researchers understand how we assess our own levels of commitment and those of others

Commitment plays a crucial role in many aspects of our lives, be it in relationships, at work or, more practically, how we approach exercise or rehab and other programmes that require long-term dedication to be effective.

24 Sep 2018

Study: Over 80% of people who carry identifiable genetic risk for cancer don't know it

Genomic screening of more than 50,000 people shows that more than 80% of those who carry an identifiable genetic risk for breast, ovarian, prostate, and pancreatic cancer don't know it despite frequent interaction with the healthcare system.

24 Sep 2018

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

Takeda Pharmaceutical Company Limited today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion, recommending the full approval of ALUNBRIG® as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer previously treated with crizotinib.

24 Sep 2018

New therapeutic vaccine helps immune cells fight HPV-related head and neck cancer

A therapeutic vaccine can boost antibodies and T cells, helping them infiltrate tumors and fight off human papillomavirus-related head and neck cancer.

24 Sep 2018

Medical Condition News

New online, sound matching tool offers tinnitus sufferers potential treatment options

Researchers analyze response to combination immunotherapy for patients with rare skin cancer

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Number of people with respiratory diseases likely to increase if UK air pollution remains unchecked

Successful recovery from addiction means more than achieving abstinence

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

Biogen and Eisai announce results of LTE Phase 1b study of aducanumab for treating MCI

Place where older adults live before hospitalization may affect risk of readmission

Researchers compare weight loss results of online and in-person diabetes prevention program

Cytox, AIBL announce expanded agreement to assess genetic risk for Alzheimer’s

CSU chemists may help in making extracorporeal life support devices more effective

New nanoplatform technology may reverse drug-resistance in renal cell carcinoma

Researchers highlight potential therapy for treating rare, deadly blood-clotting disorder

CHMP recommends approval of Gilenya for treatment of multiple sclerosis in children, adolescents

Study: Transcatheter mitral valve repair reduces mortality for patients with mitral regurgitation

China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma

Researchers understand how we assess our own levels of commitment and those of others

Study: Over 80% of people who carry identifiable genetic risk for cancer don't know it

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

New therapeutic vaccine helps immune cells fight HPV-related head and neck cancer

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News